Correspondence  |   October 2017
In Reply
Author Notes
  • Mayo Clinic College of Medicine, Jacksonville, Florida (S.J.B.).
  • (Accepted for publication June 30, 2017.)
    (Accepted for publication June 30, 2017.)×
Article Information
Correspondence   |   October 2017
In Reply
Anesthesiology 10 2017, Vol.127, 724-725. doi:10.1097/ALN.0000000000001807
Anesthesiology 10 2017, Vol.127, 724-725. doi:10.1097/ALN.0000000000001807
We wish to thank Prof. Hilary Grocott for his excellent letter and for the kind words regarding our review article1 ; we are honored by his praise. In his letter, Prof. Grocott had several important comments to which we would like to respond. First, we attempted to remind the reader that the issue of unintended patient awareness during periods of neuromuscular paralysis may occur in various clinical settings, including the intensive care unit. Specifically, it has been reported that neuromuscular blocking agents may be employed to control shivering (and decrease oxygen consumption) during induction of therapeutic hypothermia, and such therapy “may mask insufficient sedation” that may result in unintended patient awareness and recall.2  This was the basis for our inclusion of the reference.1 
First Page Preview
First page PDF preview
First page PDF preview ×
View Large